Submitted by Anonymous (not verified) on 6 August 2025 - 12:35
Human medicines European public assessment report (EPAR): Seebri Breezhaler, glycopyrronium bromide, Date of authorisation: 28/09/2012, Revision: 13, Status: Authorised
Source: